Nanotechnology in Neuroscience and Neuroengineering

Neuroengineering focuses on the development of artificial devices and novel materials to be functionally and structurally interfaced with the central nervous system (CNS). Today, there is the expectation that materials science and nanotechnology will be able to address these challenges and lead to breakthroughs at the level of the interfaces between artificial transducers/actuators and living cells. Nanoparticles are able to penetrate the BBB of in vitro and in vivo models; and therefore can be used to develop diagnostic tools as well as nano-enabled delivery systems that can bypass the BBB in order to facilitate conventional and novel neurotherapeutic interventions such as drug therapy, gene therapy, and tissue regeneration.

 

  • Up-take mechanisms of nanoparticles into brain
  • Advances in the treatment of Alzheimer’s disease with nanoparticle
  • Advances in the treatment of Parkinson’s disease with nanoparticle
  • Advances in the treatment of huntington disease with nanoparticle
  • Advances in the treatment of vascular dementia disease with nanoparticle
  • Advances in the treatment of lewd body dementia disease with nanoparticle
  • Advances in the treatment of frontotemporal disease with nanoparticle
  • Current and future development

Related Conference of Nanotechnology in Neuroscience and Neuroengineering

April 25-26, 2024

36th Nano Congress for Future Advancements

London, UK
May 16-17, 2024

27th World Nanotechnology Congress

Rome, Italy
October 24-25, 2024

7th International Conference on Nanomedicine and Nanotechnology

Zurich, Switzerland
October 24-25, 2024

11th Global Conference on Smart Materials and Nanotechnology

Zurich, Switzerland
December 02-03, 2024

10th Annual Meet on Nanoscience and Nanotechnology

Prague, Czech Republic

Nanotechnology in Neuroscience and Neuroengineering Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in